Published on: 23 February 2026

Kidney transplantation offers a crucial lifeline for patients with diabetes suffering from end-stage renal disease. However, managing metabolic health in this population remains a complex challenge. Recent research comparing specialized endocrinology-integrated transplant clinics with standard care models reveals valuable insights on metabolic control and healthcare utilization during the critical first year post-transplant. This summary delves into those findings, emphasizing implications for healthcare professionals engaged in global Muslim weight management and transplant care.

The Challenge of Metabolic Management Post-Kidney Transplant in Diabetes

Diabetes is a leading cause of kidney failure worldwide, making kidney transplantation the preferred treatment for eligible patients. Despite transplantation’s benefits, post-transplant metabolic control is often suboptimal. Immunosuppressive medications and weight gain complicate diabetes management. Consequently, patients frequently experience persistent hyperglycemia, hypertension, and dyslipidemia, all of which elevate cardiovascular risk. Effective metabolic management is vital to improving graft survival and patient outcomes. However, transplant teams may lack sufficient endocrinology expertise, leading to fragmented diabetes care.

Specialized Endocrinology-Integrated Transplant Clinics: A New Model of Care

To address these gaps, a specialized Endocrine Transplant Clinic (ETC) model was established, integrating endocrinology-led care within the transplant program. This model features a multidisciplinary team, including endocrinologists, diabetes nurse specialists, pharmacists, and dietitians with renal expertise. The goal is to provide coordinated, protocol-driven metabolic management tailored to the unique needs of kidney transplant recipients with diabetes.

Comparative Outcomes: ETC Versus Standard Care Models

A multicenter retrospective longitudinal study evaluated metabolic trajectories over 12 months in three patient cohorts: those managed in the ETC, patients receiving standard transplant care prior to ETC implementation, and recipients followed in a European academic center with routine endocrinology consultation.

Surprisingly, metabolic outcomes such as glycated hemoglobin (HbA1c), body mass index (BMI), blood pressure, and lipid profiles showed stabilization rather than improvement across all care models. More than half of the patients had HbA1c levels above recommended targets one year post-transplant. Similarly, obesity prevalence remained high, with over 30% of patients having a BMI ≥30 kg/m² throughout follow-up. Blood pressure control was inadequate in the majority, with systolic hypertension affecting nearly half to three-quarters of recipients.

These findings suggest that while the ETC model facilitated earlier adoption of contemporary glucose-lowering therapies, including GLP-1 receptor agonists, it did not translate into substantially better metabolic control compared to standard care. This highlights the complexity of metabolic management in this population and the need for more intensive, protocolized interventions.

Persistent Cardiometabolic Risk Factors Demand Multidisciplinary Attention

The study underscores persistent cardiometabolic vulnerabilities among kidney transplant recipients with diabetes. Despite specialized endocrinology involvement, many patients remained above targets for glycemic control, weight, blood pressure, and lipid levels. This situation perpetuates elevated risks for cardiovascular disease, the leading cause of morbidity and mortality post-transplant.

Therefore, integrating endocrinology care is necessary but insufficient alone. Structured lifestyle interventions, aggressive pharmacologic management, and continuous monitoring are essential. For healthcare professionals in global Muslim weight management, these findings emphasize the need to tailor multidisciplinary strategies that also consider cultural and dietary factors influencing metabolic health.

Healthcare System Differences and Their Impact

Interestingly, differences between the US and European healthcare systems, such as length of dialysis before transplantation and hospital stay duration, did not lead to markedly different metabolic outcomes. This suggests that systemic healthcare variations may have less influence on early post-transplant metabolic control than anticipated.

Nonetheless, the study found persistent disparities in transplant access based on sex, with men receiving transplants at roughly twice the rate of women. This highlights an area requiring further attention to ensure equitable care delivery.

Future Directions: Protocol-Driven and Early Intervention Strategies

The stabilization of metabolic parameters without significant improvement calls for earlier and more protocolized multidisciplinary metabolic management. Incorporating newer cardiometabolic agents such as sodium-glucose co-transporter-2 (SGLT2) inhibitors and PCSK9 inhibitors more broadly could enhance outcomes. Although their use remains limited, emerging evidence supports their safety and efficacy in transplant recipients.

Furthermore, prospective trials are needed to evaluate structured lifestyle programs combined with intensive pharmacotherapy. Such initiatives may improve cardiovascular outcomes and graft longevity, especially within culturally diverse populations requiring individualized approaches.

Conclusion: Bridging Gaps in Post-Transplant Metabolic Care for Patients with Diabetes

In summary, specialized endocrinology care within kidney transplant programs represents a promising step toward better metabolic control in patients with diabetes. However, the current evidence reveals that metabolic stabilization is more common than improvement during the first post-transplant year. Healthcare professionals should recognize that endocrinology integration alone may not suffice. Instead, early, comprehensive, and culturally sensitive interventions are essential to optimize cardiometabolic health and transplant success.

For those involved in global Muslim weight management and transplant care, these insights highlight the critical need for multidisciplinary collaboration, protocolized care pathways, and expanded use of modern therapies. Ultimately, such efforts can advance personalized metabolic management and improve long-term outcomes in this vulnerable population.

Source: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.70596

LEARN MORE ABOUT THE MUSLIM WEIGHT MANAGEMENT